Altimmune (ALT) Notes Payables (2012 - 2020)

Altimmune (ALT) reported Notes Payables of $632000.0 for Q2 2020, up 286.02% year-over-year from $163724.0 in Q3 2019, and up 501.55% quarter-over-quarter from $105062.0 in Q3 2019.

Altimmune (ALT) Notes Payables (2012 - 2020) Analysis & Trends

Altimmune (ALT) has 7 years of Notes Payables data on file, last reported at $632000.0 in Q2 2020.

  • Notes Payables for Q2 2020 came in at $632000.0, up 286.02% year-over-year; the trailing twelve-month figure through Jun 2020 was $632000.0 (up 286.02% YoY), and the FY2018 annual result was $71596.0, up 44.05% from the prior year.
  • Notes Payables improved to $632000.0 in Q2 2020 per ALT's latest filing, from $105062.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $1.5 million in Q3 2018 and troughed at $49702.0 in Q2 2017.
  • A 5-year average of $386259.6 and a median of $134393.0 in 2019 frame the typical range for Notes Payables.
  • The sharpest annual moves came in 2018 and 2019: Notes Payables soared 2852.11% in 2018, then slumped 92.84% in 2019.
  • A 5-year view of Notes Payables shows it stood at $458629.0 in 2016, then plunged by 89.16% to $49702.0 in 2017, then jumped by 44.05% to $71596.0 in 2018, then jumped by 46.74% to $105062.0 in 2019, then jumped by 501.55% to $632000.0 in 2020.
  • Business Quant data shows ALT's Notes Payables at $632000.0 in Q2 2020, $105062.0 in Q3 2019, and $163724.0 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Altimmune 336.67 Mn 336.67 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2020 632,000.00
Sep 30, 2019 105,062.00
Jun 30, 2019 163,724.00
Mar 31, 2019 227,117.00
Dec 31, 2018 71,596.00
Sep 30, 2018 1.47 Mn
Jun 30, 2018 1.31 Mn
Mar 31, 2018 49,702.00
Dec 31, 2017 49,702.00
Sep 30, 2017 49,702.00
Jun 30, 2017 49,702.00
Dec 31, 2016 458,629.00
Dec 31, 2013 1.09 Mn
Jun 30, 2013 1.17 Mn
Mar 31, 2013 1.33 Mn
Dec 31, 2012 1.33 Mn
Sep 30, 2012 1.21 Mn
Mar 31, 2012 857,808.00